<DOC>
	<DOC>NCT00947557</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background therapy of glimepiride with or without metformin.</brief_summary>
	<brief_title>Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes mellitus, diagnosed at least 3 months prior to Screening (Visit 1) BMI 20 to 48 kg/m2, inclusive HbA1c 7.0% 10.0%, inclusive Age 18 to 85 years, inclusive Currently on 3 or more oral antidiabetic drugs or insulin. Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>